{
    "code": "52026972",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026972",
    "time": "2022-01-14 05:19:00",
    "許可證字號": "衛部藥輸字第026972號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/12\/09",
    "發證\/登錄日期": "105\/12\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202697201",
    "中文品名": "賀肝樂膜衣錠",
    "英文品名": "ZEPATIER (elbasvir and grazoprevir) Tablet",
    "適應症": "Zepatier適用於治療成人的慢性C型肝炎基因型第1或第4型感染症。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/12\/09",
    "主成分略述": "Elbasvir, Grazoprevir",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市信義區信義路五段106號12樓",
    "主製造廠": [
        {
            "": "IRELAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FBE0006000  SCHERING-PLOUGH LABO N.V.",
            "製造廠廠址": "INDUSTRIEPARK 30, B-2220 HEIST-OP-DEN-BERG, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "分包裝廠"
        },
        {
            "製造廠名稱": "FPT0015000  HOVIONE FARMACIENCIA SA",
            "製造廠廠址": "SETE CASAS 2674-506 LOURES PORTUGAL",
            "製造廠公司地址": "",
            "製造廠國別": "PORTUGAL",
            "製程": "中間產物製造廠"
        },
        {
            "製造廠名稱": "FUS1051000  BEND RESEARCH, INC.",
            "製造廠廠址": "20503 BUILDERS STREET, BEND, OREGON 97701, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "中間產物製造廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818005700",
            "成分名稱": "Grazoprevir",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0818005600",
            "成分名稱": "Elbasvir",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "20201026_QRD_Zepatier_Chi_for nitial filing_approved_clean-110-06-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026972&Seq=007&Type=9"
        },
        {
            "title": "Zepatier_病患須知騎縫章-109-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026972&Seq=006&Type=9"
        },
        {
            "title": "Zepatier_外盒標籤_Final-108-10-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026972&Seq=007&Type=8"
        },
        {
            "title": "Zepatier foil_TFDA-107-01-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026972&Seq=004&Type=8"
        }
    ]
}